Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-02-15Effects of Upper Extremity Aerobic Exercise Training on Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-02-05A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-01-18Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-12-27The Prevalence of BMPR-2 Gene Mutations in Korean Patients With Pulmonary Arterial Hypertension (PAH) and the Effects of Gene Mutations on Hemodynamic Response by Drug Therapy
-
CLINICAL_TRIALS study record update · 2018-12-03A 28-Day Multiple-Dose Titration Study to Assess the Effects of MK-8892 on Safety, Tolerability and Pharmacokinetics in Subjects With Pulmonary Arterial Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-11-20Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
-
CLINICAL_TRIALS study record update · 2018-10-31A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
-
CLINICAL_TRIALS study record update · 2018-10-30A Phase 1, Single-center, Open-label, Dose-Rising Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder (TrIP) in Healthy Normal Volunteers
-
CLINICAL_TRIALS study record update · 2018-10-26Acute Hemodynamic Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-10-22A Non-randomized, Single-Panel, Open-Label Trial to Study the Safety, Tolerability and Pharmacodynamics of MK-8892 Acute Dosing in Subjects With Moderate to Severe Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-09-28The Relationship Between Myocardial 18F-FDG Uptake and Right Ventricular Coupling Obtained by PET/MRI Hybrid Imaging in Patients With Pulmonary Arterial Hypertension.
-
CLINICAL_TRIALS study record update · 2018-09-26Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-09-26A Multi-center, Open-label, Randomized Cross-over Study to Compare the Acute Tolerability and Pharmacokinetics of BAYQ6256 (Iloprost; Ventavis) Inhalation Using the I-Neb Nebulizer and the FOX Nebulizer in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-09-25Acute Effects of Oxygen Supplementation Among Pulmonary Arterial Hypertension Patients
-
CLINICAL_TRIALS study record update · 2018-09-24Effects of iNO on Invasively Derived Pulmonary Vascular Parameters in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-08-22AC-055-402: An Extension of AC-055-401, a Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
-
CLINICAL_TRIALS study record update · 2018-08-15Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
-
CLINICAL_TRIALS study record update · 2018-08-03Investigation of the Effects of Neuromuscular Electrical Stimulation in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2018-07-09Multicenter, Open-label, Non-comparative, Proof-of-concept, Phase 2a Study to Evaluate the Effect of a Single Infusion of Tezosentan on Pulmonary Vascular Resistance in Patients With Stable, Chronic Pulmonary Arterial Hypertension, Currently Not Treated With Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors or Prostacyclines
-
CLINICAL_TRIALS study record update · 2018-07-09Multi-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Demonstrate That a Single Infusion of Tezosentan Has Minimal Effect on Blood Pressure in Patients With Pulmonary Arterial Hypertension, Treated With Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors or a Combination of Both.
-
CLINICAL_TRIALS study record update · 2018-06-26Individualized Surgical Repair for Congenital Mitral Insufficiency in Infants and Children
-
CLINICAL_TRIALS study record update · 2018-05-233D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH (EVA 3D Pilot Study)
-
CLINICAL_TRIALS study record update · 2018-05-04DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study
-
CLINICAL_TRIALS study record update · 2018-05-01Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2018-04-19A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension